Market Overview

Has Eli Lilly Found A Cure For Alzheimer's?

Share:
Has Eli Lilly Found A Cure For Alzheimer's?

Shares of Eli Lilly and Co (NYSE: LLY) have risen 26 percent over the past year, in large part due to speculation that the company could become the first pharmaceutical firm to roll out a treatment for Alzheimer's disease.

This week, the company is set to present the results of its clinical trials at the Alzheimer's Association International Conference in Washington. If positive, they could mark a major step forward for both the fight against the degenerative disease as well as Eli Lilly shares.

A Pharmaceutical Gold Mine

Alzheimer's represents a pharmaceutical gold mine for drug makers as there are no known treatments that combat the disease itself. Currently, doctors can only prescribe medication that alleviates some of the symptoms for sufferers, but nothing on the market specifically targets the root of the disease itself.

Related Link: Biogen Boost: Bank Of America Upgrades Stock Ahead Of Alzheimer's Data

Solanezumab

Eli Lilly's latest drug, Solanezumab, may be the medical community's answer in the fight against Alzheimer's.

An injectable treatment, Solanezumab binds to plaque buildups in the brain that cause patients' deterioration. If the results of the clinical studies are promising, the drug could be used to treat sufferers who are still in the early stages of Alzheimer's; combined with other treatments, this may also help those with more advanced cases.

Risky Business

Solanezumab isn't a sure thing just yet. Clinical trials in 2012 showed that the drug didn't have a significant impact on mild to moderate Alzheimer's patients.

However, Eli Lilly scientists chose to continue researching the treatment despite its sky-high costs, as patients with a mild case of the disease appeared to respond positively to treatment with Solanezumab. The results of those studies, which began back in 2013, will be disclosed at Wednesday's conference.

Image Credit: Public Domain

Posted-In: Alzheimer's Association International Conference Alzheimer's diseaseHealth Care Events Top Stories General Best of Benzinga

 

Related Articles (LLY)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo

Worst Performing Industries For July 20, 2015

Wheat Futures Extend Losses